Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.590
-0.060 (-3.64%)
At close: Sep 12, 2025, 4:00 PM EDT
1.570
-0.020 (-1.26%)
After-hours: Sep 12, 2025, 7:40 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $97.61 million as of September 12, 2025. Its market cap has decreased by -87.75% in one year.
Market Cap
97.61M
Enterprise Value
-106.42M
1-Year Change
-87.75%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $97.61M, a decrease of -86.77%. That is a compound annual growth rate of -31.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 97.61M | -87.82% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |